Insider Transactions Reported by 15 Insiders of AEON Biopharma, Inc.

Symbol
AEON on NYSE
Location
Irvine, CA

Insiders trading volume in the past year

AEON Biopharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Priveterra Sponsor, LLC 10%+ Owner $138,891,630 21 Jul 2023
Strathspey Crown Holdings Group, LLC 10%+ Owner $20,317,730 11 Aug 2023
Daewoong Co., Ltd 10%+ Owner $13,216,715 21 Jan 2026
Robert E. Bancroft PRESIDENT & CEO, Director $3,526,584 17 Feb 2026
Chad Oh Chief Medical Officer $2,074,264 17 Feb 2026
Alexander Blair Wilson CLO, CSO, and Corp Secretary $2,073,854 17 Feb 2026
Jennifer Sy Principal Accounting Officer $1,426,117 17 Feb 2026
JOST FISCHER Director $130,057 +$84,550 +186% 21 May 2025
Marc Forth Director 21 May 2025
PETER A. REYNOLDS Chief Financial Officer 21 Jul 2023
Shelley B. Thunen Director 21 May 2025
Seongsoo Park Director 12 Apr 2024
Eric G. Carter Director 21 May 2025
PALMISANO ROBERT J Director 21 May 2025
BARCLAYS PLC 10%+ Owner 20 Feb 2023

Recent Insider Transactions by Companies or Individuals for AEON Biopharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.